Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting

BACKGROUND: The factors associated with non-adherence to obesity treatment using liraglutide 3.0 mg in a real-world setting remain elusive. METHODS: We performed a secondary data analysis of 769 participants treated with liraglutide 3.0 mg from December 2017 to June 2020 at nine Korean hospitals. Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Hae-Jin, Kim, Jin-Wook, Lim, Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for the Study of Obesity 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579476/
https://www.ncbi.nlm.nih.gov/pubmed/36050277
http://dx.doi.org/10.7570/jomes22029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579476/
https://www.ncbi.nlm.nih.gov/pubmed/36050277
http://dx.doi.org/10.7570/jomes22029

Ejemplares similares